
AI-generated summary
In order to thoroughly implement the spirit of party and state institutional reform, in accordance with the latest revisions involving the adjustment of human genetic resources management responsibilities in the "Biosafety Law of the People's Republic of China" and the "Regulations of the People's Republic of China on the Management of Human Genetic Resources", the National Health Commission organized and revised the "Details for the Implementation of the Regulations on the Management of Human Genetic Resources" issued by the former Ministry of Science and Technology in June 2023.
The National Health Commission today (11th) released the newly revised "Details for the Implementation of the Regulations on the Management of Human Genetic Resources".
In order to thoroughly implement the reform spirit of the party and state institutions, in accordance with the latest revisions involving the adjustment of human genetic resources management responsibilities in the "Biosafety Law of the People's Republic of China" and the "Regulations of the People's Republic of China on the Management of Human Genetic Resources", the National Health Commission organized and revised the "Details for the Implementation of the Regulations on the Management of Human Genetic Resources" issued by the former Ministry of Science and Technology in June 2023 (hereinafter referred to as the "Details").
This revision adheres to the overall coordination of development and safety, and aims at "safe management, respecting rights and interests, promoting sharing, and efficient utilization" to effectively protect and rationally utilize my country's human genetic resources, safeguard national biosecurity and social public interests, and promote high-quality development in the field of medicine and health. Revise the higher-level laws and regulations, implement legal responsibilities and reform requirements, mainly adjust the regulatory entities, optimize the approval and filing management system, improve the supervision chain, etc., to ensure the standardized, safe and efficient use of my country's human genetic resources.
The "Detailed Rules" contain eight chapters and sixty-one articles. Chapter 1 General Provisions stipulates the scope of application, relevant definitions, responsibilities of all parties, etc. Chapter 2 Investigation and Registration clarifies the responsibilities of national and provincial authorities, conducts investigations and registration of important genetic pedigrees, and establishes a dynamic list. Chapter 3 Collection of Human Genetic Resources clarifies the collection application conditions, multi-center collection procedures, etc. Chapter 4, Preservation of Human Genetic Resources, clarifies the preservation application conditions, application unit management requirements, etc. Chapter 5 uses human genetic resources to carry out international cooperation, clarifying the application conditions, application rules, cooperative research status reports, changes in matters, etc. for international cooperative scientific research. Chapter 6: The export of human genetic resource materials and the provision or open use of information to the outside world, stipulates declaration rules, simplified procedures, etc. Chapter 7, Service and Supervision, clarifies the regulatory responsibilities, supervision and inspections, emergency and rapid approval systems of competent departments at all levels.
(CCTV reporters Wen Yongyi and Shi Yingchun)

Hong Kong will become the first Asian city to conduct clinical trials of histotripsy, a non-invasive kidney tumour treatment, with the Li Ka Shing Foundation funding places for 30 patients across CUHK Medical Centre, Gleneagles Hospital Hong Kong, and Hong Kong Sanatorium & Hospital.

69-year-old Uncle Qin was pricked by a fishbone on his right palm while handling tilapia. Three days later, he developed a high fever, redness, swelling and blisters on his arms. He was diagnosed with Vibrio vulnificus infection and was discharged from the Shenzhen Third People's Hospital after 16 days of treatment. Doctors remind people to wear gloves when handling seafood, and those with wounds should avoid contact with seafood and seawater. If the wound is red, swollen and has a fever, seek medical attention immediately and inform them of the seafood bite.

You Guantang, a psychosomatic physician, pointed out that Double 11 limited-time promotions can easily induce impulse purchases. It is recommended that consumers make a list and set a budget before checking out. Store items not on the list for the next day before making a decision. If you repeatedly cannot control your shopping impulse, you can seek professional assistance.

Liu Boren, director of the Cobot Clinic, said that although black fungus contains polysaccharides that may have antioxidant and blood lipid-regulating effects, there is no clinical evidence in humans to prove that it can remove blood vessel plaques or prevent myocardial infarction. Patients taking medication should not stop taking the medicine on their own. Soaking dried black fungus at room temperature for a long time may increase the risk of contamination by microorganisms such as bunkeric acid. You should cook it as soon as possible after soaking it for a short time and keep it refrigerated if necessary.

In response to the "Health Coin" policy of the Ministry of Health and Welfare, Chimei Medical Center took the lead in China on October 22 to launch the "Colleagues Donate Blood to Get Health Points" campaign. Donating 250cc of blood will earn you 250 points, and donating 500cc will earn you 500 points, which can be used as discounts in the hospital restaurant. In the future, it is planned to be used for health examinations and self-paid vaccines. During the event, colleagues donated a total of 21,500 cc of blood. 90.6% of the participants agreed that daily health should be paid more attention to by combining health points, and 96.9% hoped that the Ministry of Health and Welfare would include blood donation in the health coin reward program.

The Ohio State University Wexner Medical Center in the United States conducted a small clinical trial in which influenza vaccine was directly injected into the tumors of 18 melanoma patients. Seven patients showed signs of tumor regression, and three patients had no cancer cells found in the surgically removed tissue. The results of the study were presented at the annual meeting of the Society for Cancer Immunotherapy in Phoenix, USA, in November. However, the trial did not have a control group and the source of the efficacy cannot yet be confirmed.